Getinge Ab Class B · OMXSTO:GETI_B

Getinge Ab Class B — Q1 2022 Earnings Presentation

18 slides from Getinge Ab Class B's earnings presentation, Apr 26, 2022

  1. Slide 1: Strong order book but facing supply chain challenges

    Strong order book but facing supply chain challenges Getinge Q1 2022 Mattias Perjos, CEO Lars Sandström, CFO

  2. Slide 2: Key takeaways

    Key takeaways Q1 2022 • Order intake and net sales impacted by challenging comps in ventilators • Order book up 21% vs Q1 2021 (adj for FX) • Net sales impacted by supply chain issues • Margins impacted by volume, mix and supply chain challenges • Free Cash Flow strengthened the financial position f

  3. Slide 3: Key activities and events

    Key activities and events Q1 2022 Offering and customers Russian invasion and supply chain challenges • Aquadis 56 – attractive offering for Ambulatory Care • Limited exposure to Russia • IN2 – modular room solutions for OR, ICU and CSSD • Supply challenges impacting negatively • Awarded a contract

  4. Slide 4: Order intake and net sales impacted by challenging comps in ventilators

    Order intake and net sales impacted by challenging comps in ventilators Supply chain challenges delaying net sales of approx. 300 MSEK Global Americas EMEA APAC Organic Order Growth -4.4% Organic Net Sales Growth -6.4% Getinge │ Presentation │ Q1 Report 2022 April 26, 2022 Page 4

  5. Slide 5: Outlook 2022

    Outlook 2022 Organic net sales growth is expected to be in the upper end of 4-6% for the full year Getinge │ Presentation │ Q1 Report 2022 April 26, 2022 Page 5

  6. Slide 6: Order Intake Bridge Q1 2021 – Q1 2022

    Tough comps in ventilators but order book 21% larger Y-o-Y (adj for FX) Order Intake Bridge Q1 2021 – Q1 2022 Organic change -7.9% -1.1% +1.3% -4.4% 137 55 -35 6,772 MSEK 6,616 Q1 2021 Acute Care Therapies Life Science Surgical Workflows Q1 2022 Getinge │ Presentation │ Q1 Report 2022 April 26, 2022

  7. Slide 7: Net Sales Bridge Q1 2021 – Q1 2022

    Challenging comps in Acute Care Therapies and delays due to supply Net Sales Bridge Q1 2021 – Q1 2022 Organic change -14.3% 19.0% -0.1% -6.4% 203 100 MSEK -289 398 Currency impact, MSEK 5.6 6,169 6,182 Organic growth, % Q1 2021 Acute Care Life Science Surgical Q1 2022 -22.4 Therapies Workflows Capit

  8. Slide 8: Adjusted Gross Profit Bridge Q1 2021 – Q1 2022

    Volume and mix effects impacting gross margin in the quarter Adjusted Gross Profit Bridge Q1 2021 – Q1 2022 Adj GM, % Q1 2022 62.2 43.2 39.1 52.7 (Q1 2021) (61.2) (42.9) (39.7) (53.3) Gross Margin impact 90 29 Volume -143 Business Area mix MSEK Factory absorption 3,285 3,261 Supply chain issues Curr

  9. Slide 9: Financial development

    Financial development Getinge │ Presentation │ Q1 Report 2022 April 26, 2022 Page 9

  10. Slide 10: Adjusted EBITA Bridge Q1 2021 – Q1 2022

    Adj EBITA margin impacted by volume and mix Adjusted EBITA Bridge Q1 2021 – Q1 2022 17.5% 13.6% Margin development -1.4 pp Adj GP -240 -1.7 pp Adj OPEX -24 -0.3 pp D&A -41 -0.5 pp Currency -51 -52 -58 -14 +23 MSEK 1,079 Currency impact, MSEK 839 Q1 2021 Adj Gross Adj Selling Adj Admin Adj R&D Other

  11. Slide 11: Positive free cash flow and continued working capital efficiency

    Positive free cash flow and continued working capital efficiency Continued efficiency enhancements Free CF impacted by inventory WC days well below 100 High Return on Invested Capital build up for strong H2 in sales 140 Reduction of >40 days 130 from the top 120 110 18.1% 2.0 100 1.4 1.3 90 1.2 7.5%

  12. Slide 12: Solid financial position

    Solid financial position Improved net debt and high margin of safety when it comes to leverage Improved net debt … … and leverage signaling financial strength 14.0 3.4x 3.0 (net cash positive 29 MSEK if excl. 0.5 pension liabilities) (0.0 x excluding pension liabilities) Q1 2019 Q2 2019 Q3 2019 Q4 2

  13. Slide 13: Summary

    Summary Getinge │ Presentation │ Q1 Report 2022 April 26, 2022 Page 13

  14. Slide 14: Key takeaways

    Key takeaways Summary Q1 2022 • Good activity level and progress on strategy implementation • Healthy order book and strong pipeline • Organic net sales growth expected to be in the upper end of the range 4-6% for FY 2022 • Margins expected to strengthen as volume increases • Solid financial positio

  15. Slide 15: Q&A

    Q&A Getinge │ Presentation │ Q1 Report 2022 April 26, 2022 Page 15

  16. Slide 16: Thank you

    Thank you Getinge │ Presentation │ Q1 Report 2022 April 26, 2022 Page 16

  17. Slide 17: Forward looking information

    Forward looking information This document contains forward-looking information based on the current expectations of the Getinge’s management. Although management deems that the expectations presented by such forward-looking information are reasonable, no guarantee can be given that these expectation

  18. Slide 18: Getinge – Passion for Life

    “= Se A GETINGE PASSION FOR LIFE

Getinge — Q1 2022 Earnings Presentation on 6ix